(Q37977481)

26 August 2017

Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment (English)

1 reference

systemic lupus erythematosus

26 August 2017

0 references

1 reference

1 reference

1 reference

4

Zahir Amoura

1 reference

26 August 2017

Laurent Arnaud

1

1 reference

26 August 2017

Alexis Mathian

series ordinal

2

1 reference

26 August 2017

Jacques Boddaert

series ordinal

3

1 reference

26 August 2017

1 March 2012

1 reference

26 August 2017

1 reference

26 August 2017

29

1 reference

26 August 2017

3

1 reference

26 August 2017

181-189

1 reference

https://scigraph.springernature.com/pub.10.2165/11598550-000000000-00000

26 August 2017

0 references

cites work

Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Systemic lupus erythematosus in 50 year olds

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Systemic lupus erythematosus in the elderly: clinical and immunological characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Systemic lupus erythematosus: clinical manifestations and immunological parameters in 194 patients. Subgroup classification of SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Late onset systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Clinical features of systemic lupus erythematosus: differences related to race and age of onset

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Systemic lupus erythematosus with disease onset after age 65

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Late onset systemic lupus erythematosus in southern Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Clinical profile of patients with late-onset SLE: not a benign subgroup

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Late onset systemic lupus erythematosus: no substantial differences using different cut-off ages.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Characteristics of patients with late onset systemic lupus erythematosus in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

A meta-analysis of the clinical manifestations of older-onset systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Drug-induced lupus: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Racial disparities in age at time of cardiovascular events and cardiovascular-related death in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Range of antinuclear antibodies in "healthy" individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

The importance of assessing medication exposure to the definition of refractory disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

Novel evidence-based systemic lupus erythematosus responder index

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598550-000000000-00000

CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES.

21 January 2018

1 reference

12 December 2020

Systemic lupus erythematosus in the elderly

1 reference

12 December 2020

Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors

1 reference

12 December 2020

Systemic lupus erythematosus in the elderly

1 reference

12 December 2020

Systemic lupus erythematosus in the elderly: clinical and serological characteristics

1 reference

12 December 2020

Age influences the clinical and serologic expression of systemic lupus erythematosus

1 reference

12 December 2020

Systemic lupus erythematosus: clinical and laboratory aspects related to age at disease onset

1 reference

12 December 2020

1 reference

12 December 2020

The effect of age on clinical and serological manifestations in unselected patients with systemic lupus erythematosus

1 reference

12 December 2020

Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.

1 reference

12 December 2020

Late onset systemic lupus erythematosus: a new approach

1 reference

12 December 2020

Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. SLE Disease Activity Index

1 reference

12 December 2020

Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center

1 reference

12 December 2020

Systemic lupus erythematosus in the older age group: computer analysis

1 reference

12 December 2020

Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases.

1 reference

12 December 2020

Systemic lupus erythematosus in later life.

1 reference

12 December 2020

Late onset lupus: a clinical and immunological study in a predominantly Chinese population.

1 reference

12 December 2020

The clinical features and prognosis of lupus with disease onset at age 65 and older

1 reference

12 December 2020

Systemic lupus erythematosus in the elderly

1 reference

12 December 2020

Why all systemic lupus erythematosus patients should be given hydroxychloroquine treatment?

1 reference

12 December 2020

Systemic lupus erythematosus in the aged: clinical and laboratory characteristics

1 reference

12 December 2020

The rate and pattern of organ damage in late onset systemic lupus erythematosus

1 reference

12 December 2020

Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies

1 reference

12 December 2020

CLINICAL ONSET OF LUPUS ERYTHEMATOSUS IN THE OLDER AGE GROUP

1 reference

12 December 2020

INCIDENCE OF SYSTEMIC LUPUS ERYTHEMATOSUS BY AGE AND SEX

1 reference

12 December 2020

Systemic lupus erythematosus in a multiethnic US cohort: Clinical features, course, and outcome in patients with late-onset disease

1 reference

12 December 2020

The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe

1 reference

12 December 2020

Late-onset systemic lupus erythematosus: clinical and immunological characteristics

1 reference

12 December 2020

Differences in clinical and immunological findings of systemic lupus erythematosus related to age

1 reference

12 December 2020

10.2165/11598550-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

0 references

1 reference